Medical Devices Startups

Medway Air Ambulance operates its own fleet of 16 Learjet aircraft equipped for up to ICU-level care, providing medical air transport for patients across the US, North America, and internationally. The company staffs full-time medical providers, including a dedicated neonatal and pediatric team, and is an FAA Part 135 licensed provider.

1 investor

MedXcribe provides AI-powered medical transcription services for healthcare professionals, researchers, and institutions to convert voice recordings into accurate medical documentation. The platform operates both offline on mobile devices and through cloud-based solutions, with AI models trained to recognize medical terminology.

1 investor

MedXT provides cloud-based software for managing medical imaging data, including X-rays, CT scans, and MRIs, serving imaging centers, hospitals, and radiology practices with tools for secure access, data sharing, and integration with radiology information systems.

1 investor

Meep develops biological monitoring technology to enable frequent clinical-grade testing for chronic disease patients, reducing unnecessary hospitalizations and intensive care admissions.

1 investor

Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.

1 investor

Melior Discovery provides in vivo pharmacology services and phenotypic screening platforms for pharmaceutical and biopharmaceutical companies to evaluate candidate therapeutics in animal disease models. The company operates proprietary technology including theraTRACE® to identify new therapeutic potential and support drug development and repositioning.

1 investor

Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.

1 investor

Mellon Medical manufactures a surgical instrument for abdominal wall closure featuring a double-pointed needle, ergonomic jaws, and atraumatic needle-suture combination.

1 investor

Melodi Health is a medical device company focused on breast reconstruction and breast procedures, developing implantable combination devices with expertise in infection control and plastic reconstructive surgery.

1 investor

Melody International develops IoT medical devices and digital platforms for maternal and fetal monitoring, aimed at maternal care providers and expectant mothers. The company focuses on improving safe childbirth and closing healthcare gaps in prenatal care.

1 investor

MELTIN develops cyborg technology by integrating robotics, artificial intelligence, and medical engineering to create medical devices and solutions. The company serves the medical device and healthcare sectors globally.

1 investor

MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers. The test serves physicians and hospitals to reduce inappropriate antibiotic prescriptions and improve patient outcomes in acute infection management.

1 investor

Mendota Health operates wound care centers focused on treating chronic wounds and preventing amputations through clinical expertise and integrated care delivery.

1 investor

Mente Medical tracks surgical instruments in operating rooms to provide real-time data on resource management and OR operations. The company develops applications to predict surgery duration, anticipate tool needs, and optimize tool inventory across hospital workflows.

1 investor

Merck is a science-led pharmaceutical company that develops medicines and vaccines for patients globally. The company focuses on innovation and long-term value creation through its research pipeline and commitment to healthcare advancement.

1 investor

Meril designs and manufactures medical devices across areas including vascular and peripheral intervention, cardiac surgery, orthopedics, endo-surgery, ENT, urology, diagnostics, and surgical robotics for hospitals, clinicians, and surgeons. Its products are made in-house in India and distributed internationally, with its ENT line present in more than 50 countries.

1 investor

Mesosil develops nanomaterial platform technology for dental materials and other applications, focusing on host-biomaterial interactions and infection prevention. The company was founded based on over a decade of nanotechnology research from its founder's doctoral work.

1 investor

META-BIOMED manufactures biodegradable surgical sutures, dental products, and bone restoration materials for orthopedic applications, serving healthcare providers globally. The company operates as a technology-intensive medical device manufacturer with products exported to over 80 countries.

1 investor

Metabolomic Diagnostics develops diagnostic tests using mass spectrometry and biomarker analysis, with a focus on women's health and pregnancy-related diseases. The company serves clinical laboratories and healthcare professionals through analytical innovation and diagnostic assay development.

1 investor

metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.

1 investor

Metastem is developing a therapy for advanced metastatic cancers. The company is in clinical development stage.

1 investor

metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.

1 investor

Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases. The company works on a medical intervention for hypertension and related metabolic conditions.

1 investor

Method Surgical AI develops an ultrasound imaging platform for surgical guidance that uses AI to generate real-time 3D subsurface maps for surgeons, designed to improve outcomes in robotic and minimally invasive cancer surgery.

1 investor